XML 64 R43.htm IDEA: XBRL DOCUMENT v3.22.0.1
SHARE-BASED COMPENSATION PLANS AND AWARDS (Tables)
12 Months Ended
Dec. 31, 2021
Share-based Payment Arrangement [Abstract]  
Schedule of Assumptions Used in the Determination of Fair Value of Stock Options Awarded The weighted average assumptions used in the determination of fair value for stock options awarded in 2021, 2020, and 2019 are provided in the table below:
Assumptions202120202019
Expected volatility rate28.99%21.56%19.80%
Expected dividend yield3.58%3.30%2.51%
Average risk-free interest rate0.95%0.94%2.44%
Expected term years6.05.95.7
Schedule of Activity of Stock Option Awards A summary of the activity of the Company's stock option awards for 2021, 2020, and 2019 is presented below:
 202120202019
 OptionsWeighted-Average Exercise PriceOptionsWeighted-Average Exercise PriceOptionsWeighted-Average Exercise Price
Outstanding at beginning of year3,526,600 $79 3,479,300 $80 2,905,600 $79 
Granted449,700 109 622,000 62 786,000 81 
Exercised(807,200)77 (568,800)64 (135,700)67 
Cancelled, forfeited, or expired(600)74 (5,900)82 (76,600)88 
Outstanding at end of year3,168,500 $84 3,526,600 $79 3,479,300 $80 
Options exercisable at year-end2,047,500 2,192,300 2,077,600 
Available for grant at end of year9,866,480 4,046,748 6,085,857 
Schedule of Remaining Contractual Term and Weighted Average Exercise Price of Stock Options Outstanding and Exercisable The following table provides the remaining contractual term and weighted average exercise prices of stock options outstanding and exercisable at December 31, 2021:
 Options OutstandingOptions Exercisable
Range of Exercise PricesNumber Outstanding at
December 31, 2021
Weighted-Average Remaining Contractual Life (Years)Weighted-Average Exercise PriceNumber Exercisable at
December 31, 2021
Weighted-Average Exercise Price
$61-$70843,4006.8$63 420,900$64 
$71-$80702,8004.878 678,80078 
$81-$90630,4006.583 405,50084 
$91-$109991,9007.5106 542,300104 
 3,168,5006.5$84 2,047,500$83 
Schedule of Summary of Status of Nonvested Options A summary of the changes in the Company's nonvested options during the year ended December 31, 2021 is presented below:
Nonvested OptionsNumber of OptionsWeighted-Average Grant Date Fair Value
Nonvested at January 1, 20211,334,300 $11.11
Granted449,700 $19.81
Vested(663,000)$12.33
Nonvested options at December 31, 20211,121,000 $13.88